Literature DB >> 28041994

A Dominant Mutation in Rpe65, D477G, Delays Dark Adaptation and Disturbs the Visual Cycle in the Mutant Knock-In Mice.

Younghwa Shin1, Gennadiy Moiseyev1, Dibyendu Chakraborty1, Jian-Xing Ma2.   

Abstract

RPE65 is an indispensable component of the retinoid visual cycle in vertebrates, through which the visual chromophore 11-cis-retinal (11-cis-RAL) is generated to maintain normal vision. Various blinding conditions in humans, such as Leber congenital amaurosis and retinitis pigmentosa (RP), are attributed to either homozygous or compound heterozygous mutations in RPE65. Herein, we investigated D477G missense mutation, an unprecedented dominant-acting mutation of RPE65 identified in patients with autosomal dominant RP. We generated a D477G knock-in (KI) mouse and characterized its phenotypes. Although RPE65 protein levels were decreased in heterozygous KI mice, their scotopic, maximal, and photopic electroretinography responses were comparable to those of wild-type (WT) mice in stationary condition. As shown by high-performance liquid chromatography analysis, levels of 11-cis-RAL in fully dark-adapted heterozygous KI mice were similar to that in WT mice. However, kinetics of 11-cis-RAL regeneration after light exposure were significantly slower in heterozygous KI mice compared with WT and RPE65 heterozygous knockout mice. Furthermore, heterozygous KI mice exhibited lower A-wave recovery compared with WT mice after photobleaching, suggesting a delayed dark adaptation. Taken together, these observations suggest that D477G acts as a dominant-negative mutant of RPE65 that delays chromophore regeneration. The KI mice provide a useful model for further understanding of the pathogenesis of RP associated with this RPE65 mutant and for the development of therapeutic strategies.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28041994      PMCID: PMC5389371          DOI: 10.1016/j.ajpath.2016.11.004

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  RPE65 is the isomerohydrolase in the retinoid visual cycle.

Authors:  Gennadiy Moiseyev; Ying Chen; Yusuke Takahashi; Bill X Wu; Jian-Xing Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

2.  Mutations in RPE65 cause Leber's congenital amaurosis.

Authors:  F Marlhens; C Bareil; J M Griffoin; E Zrenner; P Amalric; C Eliaou; S Y Liu; E Harris; T M Redmond; B Arnaud; M Claustres; C P Hamel
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

Review 3.  Review and update on the molecular basis of Leber congenital amaurosis.

Authors:  Oscar Francisco Chacon-Camacho; Juan Carlos Zenteno
Journal:  World J Clin Cases       Date:  2015-02-16       Impact factor: 1.337

4.  Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus.

Authors:  H Yamamoto; A Simon; U Eriksson; E Harris; E L Berson; T P Dryja
Journal:  Nat Genet       Date:  1999-06       Impact factor: 38.330

5.  Delayed dark adaptation in 11-cis-retinol dehydrogenase-deficient mice: a role of RDH11 in visual processes in vivo.

Authors:  Tom S Kim; Akiko Maeda; Tadao Maeda; Cynthia Heinlein; Natalia Kedishvili; Krzysztof Palczewski; Peter S Nelson
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

6.  Mutations in the gene encoding lecithin retinol acyltransferase are associated with early-onset severe retinal dystrophy.

Authors:  D A Thompson; Y Li; C L McHenry; T J Carlson; X Ding; P A Sieving; E Apfelstedt-Sylla; A Gal
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

7.  Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis.

Authors:  H Morimura; G A Fishman; S A Grover; A B Fulton; E L Berson; T P Dryja
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

8.  Identification and characterization of all-trans-retinol dehydrogenase from photoreceptor outer segments, the visual cycle enzyme that reduces all-trans-retinal to all-trans-retinol.

Authors:  A Rattner; P M Smallwood; J Nathans
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

9.  The clinical features of retinal disease due to a dominant mutation in RPE65.

Authors:  Sarah Hull; Rajarshi Mukherjee; Graham E Holder; Anthony T Moore; Andrew R Webster
Journal:  Mol Vis       Date:  2016-06-10       Impact factor: 2.367

10.  Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration.

Authors:  Francesca Simonelli; Albert M Maguire; Francesco Testa; Eric A Pierce; Federico Mingozzi; Jeannette L Bennicelli; Settimio Rossi; Kathleen Marshall; Sandro Banfi; Enrico M Surace; Junwei Sun; T Michael Redmond; Xiaosong Zhu; Kenneth S Shindler; Gui-Shuang Ying; Carmela Ziviello; Carmela Acerra; J Fraser Wright; Jennifer Wellman McDonnell; Katherine A High; Jean Bennett; Alberto Auricchio
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454

View more
  14 in total

1.  Aberrant RNA splicing is the major pathogenic effect in a knock-in mouse model of the dominantly inherited c.1430A>G human RPE65 mutation.

Authors:  Yan Li; Rachel Furhang; Amanda Ray; Todd Duncan; Joseph Soucy; Rashid Mahdi; Vijender Chaitankar; Linn Gieser; Eugenia Poliakov; Haohua Qian; Pinghu Liu; Lijin Dong; Igor B Rogozin; T Michael Redmond
Journal:  Hum Mutat       Date:  2019-01-25       Impact factor: 4.878

2.  Insights into the pathogenesis of dominant retinitis pigmentosa associated with a D477G mutation in RPE65.

Authors:  Elliot H Choi; Susie Suh; Christopher L Sander; Christian J Ortiz Hernandez; Elizabeth R Bulman; Nimesh Khadka; Zhiqian Dong; Wuxian Shi; Krzysztof Palczewski; Philip D Kiser
Journal:  Hum Mol Genet       Date:  2018-07-01       Impact factor: 6.150

3.  Two-year progression analysis of RPE65 autosomal dominant retinitis pigmentosa.

Authors:  Ruben Jauregui; Karen Sophia Park; Stephen H Tsang
Journal:  Ophthalmic Genet       Date:  2018-08       Impact factor: 1.803

4.  Noninvasive Electroretinographic Procedures for the Study of the Mouse Retina.

Authors:  Junzo Kinoshita; Neal S Peachey
Journal:  Curr Protoc Mouse Biol       Date:  2018-03

5.  A novel phenotype in a family with autosomal dominant retinal dystrophy due to c.1430A > G in retinoid isomerohydrolase (RPE65) and c.37C > T in bestrophin 1 (BEST1).

Authors:  Juanita Pappalardo; Rachael C Heath Jeffery; Jennifer A Thompson; Enid Chelva; Quang Pham; Ian J Constable; Terri L McLaren; Tina M Lamey; John N De Roach; Fred K Chen
Journal:  Doc Ophthalmol       Date:  2021-01-29       Impact factor: 2.379

Review 6.  Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy.

Authors:  Albert M Maguire; Jean Bennett; Elena M Aleman; Bart P Leroy; Tomas S Aleman
Journal:  Mol Ther       Date:  2020-12-03       Impact factor: 11.454

Review 7.  Retinal pigment epithelium 65 kDa protein (RPE65): An update.

Authors:  Philip D Kiser
Journal:  Prog Retin Eye Res       Date:  2021-10-02       Impact factor: 19.704

8.  Generation and Characterization of Induced Pluripotent Stem Cells and Retinal Organoids From a Leber's Congenital Amaurosis Patient With Novel RPE65 Mutations.

Authors:  Guilan Li; Guanjie Gao; Panfeng Wang; Xiaojing Song; Ping Xu; Bingbing Xie; Tiancheng Zhou; Guangjin Pan; Fuhua Peng; Qingjiong Zhang; Jian Ge; Xiufeng Zhong
Journal:  Front Mol Neurosci       Date:  2019-09-11       Impact factor: 5.639

9.  Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy.

Authors:  Paul F Kenna; Marian M Humphries; Anna-Sophia Kiang; Philippe Brabet; Laurent Guillou; Ema Ozaki; Matthew Campbell; G Jane Farrar; Robert Koenekoop; Pete Humphries
Journal:  BMJ Open Ophthalmol       Date:  2020-05-05

10.  Phenotypic expansion of autosomal dominant retinitis pigmentosa associated with the D477G mutation in RPE65.

Authors:  Ruben Jauregui; Ahra Cho; Jin Kyun Oh; Akemi J Tanaka; Janet R Sparrow; Stephen H Tsang
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.